+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

South America Electrophysiology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product and Indication

  • PDF Icon

    Report

  • 131 Pages
  • September 2022
  • The Insight Partners
  • ID: 5668512
UP TO OFF until Mar 31st 2024
The SAM electrophysiology market is expected to grow from US$ 501.31 million in 2022 to US$ 853.82 million by 2028; it is estimated to grow at a CAGR of 9.3% from 2022 to 2028.

The geriatric population is prone to various ailments, such as abdominal discomfort and cardiovascular disease. The growing aging population base and the increasing prevalence of cardiac arrhythmia are a few of the major factors driving the electrophysiology market growth. Electrophysiological devices are used to diagnose these disorders in the geriatric population. According to the World Health Organization (WHO), the geriatric population worldwide will grow from ~1 billion in 2019 to ~2.1 billion by 2050. Therefore, market players are developing effective products to cater to the growing patient population that will benefit the electrophysiology market growth.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM electrophysiology market at a substantial CAGR during the forecast period.

SAM Electrophysiology Market Segmentation

The SAM electrophysiology market is segmented based on product, indication, and country.
  • Based on product, the market is segmented into electrophysiology ablation catheters, electrophysiology laboratory devices, electrophysiology diagnostic catheters, access devices, and others. The electrophysiology laboratory devices segment dominated the market in 2022 and electrophysiology ablation catheters segment is expected to be fastest growing during forecast period.
  • Based on indication, the market is segmented into atrial fibrillation (AF), atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), wolff-parkinson-white syndrome (WPW), and others. The atrial fibrillation (AF) segment dominated the market in 2022 and is expected to be fastest growing during forecast period.
  • Based on country, the SAM electrophysiology market is segmented into Brazil, Argentina, and the Rest of SAM.
Abbott; Biotronik, Inc.; Boston Scientific Corporation; CardioFocus; GE Healthcare; Johnson & Johnson Services, Inc.; Koninklijke Philips N.V.; Medtronic; MicroPort Scientific Corporation; and Siemens Healthineers AG are among the leading companies operating in the SAM electrophysiology market.
Frequently Asked Questions about the South American Electrophysiology Market

What is the estimated value of the South American Electrophysiology Market?

The South American Electrophysiology Market was estimated to be valued at $501.31 Million in 2022.

What is the growth rate of the South American Electrophysiology Market?

The growth rate of the South American Electrophysiology Market is 9.3%, with an estimated value of $853.82 Million by 2028.

What is the forecasted size of the South American Electrophysiology Market?

The South American Electrophysiology Market is estimated to be worth $853.82 Million by 2028.

Who are the key companies in the South American Electrophysiology Market?

Key companies in the South American Electrophysiology Market include Abbott, Biotronik, Inc., Boston Scientific Corporation, CardioFocus, GE Healthcare, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Medtronic, MicroPort Scientific Corporation and Siemens Healthineers AG.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Electrophysiology Market - By Product
1.3.2 SAM Electrophysiology Market - By Indication
1.3.3 SAM Electrophysiology Market - By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Electrophysiology Market - Market Landscape
4.1 Overview
4.2 SAM PEST Analysis
4.3 Experts Opinion
5. Electrophysiology Market- Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Target Diseases and Procedures
5.1.2 Growing Geriatric Population
5.2 Market Restraints
5.2.1 High Cost of Electrophysiology Products and Inadequate Reimbursement Process
5.3 Market Opportunities
5.3.1 Rising Number of Emerging Markets
5.4 Future Trends
5.4.1 Increasing Advancements, Product Launches, and Approvals
5.5 Impact Analysis
6. Electrophysiology Market- SAM Analysis
6.1 SAM Electrophysiology Market Revenue Forecast and Analysis
7. SAM Electrophysiology Market Analysis - By Product
7.1 Overview
7.2 SAM Electrophysiology Market, By Product, 2022 & 2028 (%)
7.3 Electrophysiology Ablation Catheters
7.3.1 Overview
7.3.2 Electrophysiology Ablation Catheters: Electrophysiology Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Electrophysiology Laboratory Devices
7.4.1 Overview
7.4.2 Electrophysiology Laboratory Devices: Electrophysiology Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Electrophysiology Diagnostic Catheters
7.5.1 Overview
7.5.2 Electrophysiology Diagnostic Catheters: Electrophysiology Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Access Devices
7.6.1 Overview
7.6.2 Access Devices: Electrophysiology Market Revenue and Forecasts to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Electrophysiology Market Revenue and Forecasts to 2028 (US$ Million)
8. SAM Electrophysiology Market Analysis - By Indication
8.1 Overview
8.2 SAM Electrophysiology Market Revenue Share, by Indication (2022 and 2028)
8.3 Atrial Fibrillation
8.3.1 Overview
8.3.2 Atrial Fibrillation: Electrophysiology Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Atrial Flutter
8.4.1 Overview
8.4.2 Atrial Flutter: Electrophysiology Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Wolff-Parkinson-White (WPW) Syndrome
8.5.1 Overview
8.5.2 Wolff-Parkinson-White (WPW) Syndrome: Electrophysiology Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
8.6.1 Overview
8.6.2 Atrioventricular Nodal Re-entry Tachycardia (AVNRT): Electrophysiology Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Electrophysiology Market - Revenue and Forecast to 2028 (US$ Million)
9. SAM Electrophysiology Market - Country Analysis
9.1 Overview
9.1.2 SAM: Electrophysiology Market, by Country, 2022 & 2028 (%)
9.1.2.1 Brazil: Electrophysiology Market - Revenue and Forecast to 2028 (USD Million)
9.1.2.1.1 Overview
9.1.2.1.2 Brazil: Electrophysiology Market - Revenue and Forecast to 2028 (USD Million)
9.1.2.1.3 Brazil: Electrophysiology Market, By Product, 2019-2028 (USD Million)
9.1.2.1.4 Brazil: Electrophysiology Market, by Indication, 2019-2028 (USD Million)
9.1.2.2 Argentina: Electrophysiology Market - Revenue and Forecast to 2028 (USD Million)
9.1.2.2.1 Overview
9.1.2.2.2 Argentina: Electrophysiology Market - Revenue and Forecast to 2028 (USD Million)
9.1.2.2.3 Argentina: Electrophysiology Market, By Product, 2019-2028 (USD Million)
9.1.2.2.4 Argentina: Electrophysiology Market, by Indication, 2019-2028 (USD Million)
9.1.2.3 Rest of SAM: Electrophysiology Market - Revenue and Forecast to 2028 (USD Million)
9.1.2.3.1 Overview
9.1.2.3.2 Rest of SAM: Electrophysiology Market - Revenue and Forecast to 2028 (USD Million)
9.1.2.3.3 Rest of SAM: Electrophysiology Market, By Product, 2019-2028 (USD Million)
9.1.2.3.4 Rest of SAM: Electrophysiology Market, by Indication, 2019-2028 (USD Million)
10. SAM Electrophysiology Market-Industry Landscape
10.1 Overview
10.2 Organic Developments
10.2.1 Overview
10.2.2 Organic Growth Strategies in The Electrophysiology Market, 2022-2028
10.3 Inorganic Developments
10.3.1 Overview
10.3.2 Inorganic Growth Strategies in The Electrophysiology Market, 2022-2028
11. Company Profiles
11.1 Abbott
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Biotronik, Inc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Boston Scientific Corporation
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 CardioFocus.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 GE Healthcare
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Koninklijke Philips N.V.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Johnson & Johnson Services, Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Medtronic
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 MicroPort Scientific Corporation
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Siemens Healthineers AG
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About the Publisher
12.2 Glossary of Terms

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott
  • Biotronik, Inc.
  • Boston Scientific Corporation
  • CardioFocus
  • GE Healthcare
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.
  • Medtronic
  • MicroPort Scientific Corporation
  • Siemens Healthineers AG